Results 151 to 160 of about 10,400 (184)

Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug development. [PDF]

Front Pharmacol
Gómez-Cebrián N, Trull MC, Gras-Colomer E, Edo Solsona MD, Poveda Andrés JL, Puchades-Carrasco L.   +5 more
europepmc   +1 more source

Inhibition of systemic mammalian metabolism by carnitine mimics from the gut microbiota

Thümmler K, Basak S, Hulme H, Dritsa C, Foreman R, Naseer H, Salah E, Tumber A, Worboys S, Douce G, Haggarty J, Williams R, Taylor V, Ormsby MJ, Whitfield PD, McCullagh JSO, Salt IP, Burchmore R, Goodwin RJA, Schofield CJ, Wall DM.   +20 more
europepmc   +1 more source

Aging Effects on Lipid Metabolism in Response to Traumatic Brain Injury. [PDF]

J Neurochem
Fernandez RF, Weglarczyk P, Zokaei S, Huguenin S, Scafidi J, Ellis JM, Scafidi S.   +6 more
europepmc   +1 more source

MicroRNA-21 promotes dysregulated lipid metabolism and hepatocellular carcinoma.

Dis Model Mech
VanSant-Webb C, Castro JC, Su AY, Hawkins K, Saxena A, Wright J, Smith R, Fragoso-García M, Chen YA, Barton C, Stubben C, O'Connell RM, Ducker GS, Evason KJ.   +13 more
europepmc   +1 more source

Matrix effects influence biochemical signatures and metabolite quantification in dried blood spots

Cremer J, Juric V, Koch J, Scholl-Bürgi S, Karall D, Zschocke J, Keller MA.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Plasma acylcarnitines inadequately reflect tissue acylcarnitine metabolism

Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014
Acylcarnitines have been linked to obesity-induced insulin resistance. However the majority of these studies have focused on acylcarnitines in plasma. It is currently unclear to what extent plasma levels of acylcarnitines reflect tissue acylcarnitine metabolism.
Schooneman, Marieke G., Achterkamp, Niki, Argmann, Carmen A., Soeters, Maarten R., Houten, Sander M.   +4 more
openaire   +3 more sources

Acylcarnitines in intermediary metabolism

European Journal of Pediatrics, 1995
From the time of its discovery in 1905 until the first description of its deficiency in 1973, the role of carnitine in intermediary metabolism was decidedly vague. Identification of carnitine acyl transferases and their products, acylcarnitines, have paved the way to the confirmation of the importance of carnitine in the transfer of fatty acid CoAs ...
A C, Sewell, H J, Böhles
openaire   +2 more sources